Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.
01 1NURAY CHEMICALS PRIVATE LIMITED
02 1DSM Nutritional Products LLC
03 1DSM Nutritional Products Ltd.
04 1Medisca Inc.
05 1QINGDAO TIDA BIOTEK CO.,LTD
06 1STHREE CHEMICALS PRIVATE LIMITED
07 4Zhejiang Kingland Pharmaceutical Company Limited
08 1Zhejiang Shengda Bio-Pharm Co., Ltd.
01 2BIOTIN
02 8Biotin
03 1Biotin,USP(Vitamin H)
01 1China
02 1India
03 2Netherlands
04 1U.S.A
05 6Blank
Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.
NDC Package Code : 58159-118
Start Marketing Date : 2024-12-30
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (35kg/35kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 38779-3318
Start Marketing Date : 2024-12-06
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 63238-3150
Start Marketing Date : 2017-12-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 63238-3150
Start Marketing Date : 2022-12-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 83511-009
Start Marketing Date : 2024-12-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (35kg/35kg)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
NDC Package Code : 84824-003
Start Marketing Date : 2024-10-14
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
NDC Package Code : 84824-003
Start Marketing Date : 2024-10-14
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
NDC Package Code : 84824-003
Start Marketing Date : 2024-10-14
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
NDC Package Code : 84824-003
Start Marketing Date : 2024-10-14
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
NDC Package Code : 67421-002
Start Marketing Date : 2024-08-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
92
PharmaCompass offers a list of Biotin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Biotin manufacturer or Biotin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Biotin manufacturer or Biotin supplier.
PharmaCompass also assists you with knowing the Biotin API Price utilized in the formulation of products. Biotin API Price is not always fixed or binding as the Biotin Price is obtained through a variety of data sources. The Biotin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A cis-Tetrahydro-2-oxothieno(3,4-d)imidazoline-4-valeric acid manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of cis-Tetrahydro-2-oxothieno(3,4-d)imidazoline-4-valeric acid, including repackagers and relabelers. The FDA regulates cis-Tetrahydro-2-oxothieno(3,4-d)imidazoline-4-valeric acid manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. cis-Tetrahydro-2-oxothieno(3,4-d)imidazoline-4-valeric acid API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of cis-Tetrahydro-2-oxothieno(3,4-d)imidazoline-4-valeric acid manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A cis-Tetrahydro-2-oxothieno(3,4-d)imidazoline-4-valeric acid supplier is an individual or a company that provides cis-Tetrahydro-2-oxothieno(3,4-d)imidazoline-4-valeric acid active pharmaceutical ingredient (API) or cis-Tetrahydro-2-oxothieno(3,4-d)imidazoline-4-valeric acid finished formulations upon request. The cis-Tetrahydro-2-oxothieno(3,4-d)imidazoline-4-valeric acid suppliers may include cis-Tetrahydro-2-oxothieno(3,4-d)imidazoline-4-valeric acid API manufacturers, exporters, distributors and traders.
click here to find a list of cis-Tetrahydro-2-oxothieno(3,4-d)imidazoline-4-valeric acid suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing cis-Tetrahydro-2-oxothieno(3,4-d)imidazoline-4-valeric acid as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for cis-Tetrahydro-2-oxothieno(3,4-d)imidazoline-4-valeric acid API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture cis-Tetrahydro-2-oxothieno(3,4-d)imidazoline-4-valeric acid as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain cis-Tetrahydro-2-oxothieno(3,4-d)imidazoline-4-valeric acid and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a cis-Tetrahydro-2-oxothieno(3,4-d)imidazoline-4-valeric acid NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of cis-Tetrahydro-2-oxothieno(3,4-d)imidazoline-4-valeric acid suppliers with NDC on PharmaCompass.
We have 4 companies offering cis-Tetrahydro-2-oxothieno(3,4-d)imidazoline-4-valeric acid
Get in contact with the supplier of your choice:
